This inventor holds 1 USPTO granted patent. Top assignee: Cancer Research Technology Limited. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Innovations in Cancer Treatment by Liangli Zhao
Introduction
Liangli Zhao is a notable inventor based in Mt. Roskill, New Zealand. He has made significant contributions to the field of cancer treatment through his innovative research and development of anti-cancer compositions.
Latest Patents
Zhao holds a patent for an anti-cancer composition comprising DMXAA or related compounds. This invention focuses on the use of compounds from the xanthenone acetic acid class, particularly 5,6-dimethylxanthenone-4-acetic acid (DMXAA). The patent outlines a method for administering these compounds gastrointestinally, preferably orally, to treat cancer. The invention emphasizes delivering the compound to the site of action in the patient in two or more doses for enhanced effectiveness.
Career Highlights
Liangli Zhao has established himself as a key figure in cancer research. His work at Cancer Research Technology Limited has been instrumental in advancing therapeutic options for cancer patients. His dedication to innovation in this field has garnered attention and respect from his peers.
Collaborations
Zhao has collaborated with notable colleagues, including Bruce Charles Baguley and Lai-Ming Ching. These partnerships have contributed to the development and refinement of his research initiatives.
Conclusion
Liangli Zhao's contributions to cancer treatment through his patented innovations highlight the importance of research and collaboration in the medical field. His work continues to pave the way for new therapeutic approaches in oncology.